Interesting facts
Interesting Facts about N-[1-(Hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
This compound, a derivative of quinoline, comes from a class known for their versatile applications in medicinal chemistry. Here are some fascinating insights about this compound:
- Pharmacological Potential: Compounds containing the indole and quinoline structures are often studied for their biological activities, including potential anti-cancer, anti-inflammatory, and anti-microbial properties.
- Structure Activity Relationship (SAR): The specific arrangement of atoms and functional groups in this compound influences its interaction with biological targets, making it an interesting candidate for drug design.
- Bioavailability: Its hydroxymethyl group may enhance solubility and stability, which can contribute to improved bioavailability when administered as a drug.
- Natural Occurrence: Some related indoloquinoline compounds are found in nature, inspiring synthetic variations like this one due to their interesting biological activities and potential therapeutic effects.
- Research Interest: This compound is a subject of ongoing research, especially in the fields of medicinal chemistry and pharmacology, prompting scientists to explore new synthetic pathways and modifications.
In summary, N-[1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide is a unique compound that exemplifies the intricate relationship between chemical structure and biological function. Its potential applications in developing new therapeutic agents make it an exciting topic of study in modern chemistry.
Synonyms
Isomethergine
Methergine
MLS000756415
DTXSID10859203
N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
54808-91-2
Methergin (Salt/Mix)
NSC186067
Methergine (Salt/Mix)
CHEMBL1597692
SCHEMBL16092804
BDBM86237
CHEBI:91798
DTXCID30204635
UNBRKDKAWYKMIV-UHFFFAOYSA-N
HMS2231B08
HMS3369A11
CAS_8226
NSC_8226
NSC-186067
SMR000528720
N-[.alpha.-(Hydroxymethyl)propyl]-D-lysergamide
L000928
BRD-A63667919-103-01-9
Q27163599
9,10-Didehydro-N-(.alpha.-(hydroxymethyl)propyl)-6-methyl-ergoline-8-.beta.-carboxamide
9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8.beta.-carboxamide
Ergoline-8.beta.-carboxamide, 9,10-didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methyl-
(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0(2),.0(1)(2),(1)]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
479-03-8
Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-, (8.beta.)-
Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-, (8beta)-
Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-6-methyl-, [8.beta.(S)]-
N-[1-(Hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide, [8.beta.(S)]- #
Solubility of N-[1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
The solubility of N-[1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide, with the chemical formula C21H27N3O2, can be quite intriguing due to its structural complexity. This compound's solubility characteristics can influence its applications significantly. Here are some key points:
In conclusion, while specific solubility values are essential, this compound's solubility behavior is primarily dictated by its structural features and external conditions. Further experimentation and analysis are vital for comprehensive insights into its solubility profile.